Pensionfund DSM Netherlands trimmed its position in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 19.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,719 shares of the real estate investment trust's stock after selling 37,000 shares during the quarter. Healthcare Realty Trust makes up approximately 1.6% of Pensionfund DSM Netherlands' portfolio, making the stock its 20th largest position. Pensionfund DSM Netherlands' holdings in Healthcare Realty Trust were worth $2,555,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its position in Healthcare Realty Trust by 38.1% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,276 shares of the real estate investment trust's stock worth $38,000 after acquiring an additional 628 shares during the period. Signaturefd LLC grew its position in Healthcare Realty Trust by 3.4% during the third quarter. Signaturefd LLC now owns 24,912 shares of the real estate investment trust's stock valued at $452,000 after purchasing an additional 823 shares in the last quarter. Victory Capital Management Inc. increased its stake in Healthcare Realty Trust by 1.1% in the 2nd quarter. Victory Capital Management Inc. now owns 81,598 shares of the real estate investment trust's stock valued at $1,345,000 after buying an additional 848 shares during the period. Vanguard Personalized Indexing Management LLC lifted its position in Healthcare Realty Trust by 1.4% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 66,654 shares of the real estate investment trust's stock worth $1,098,000 after buying an additional 929 shares in the last quarter. Finally, Private Advisor Group LLC grew its holdings in shares of Healthcare Realty Trust by 3.6% during the 3rd quarter. Private Advisor Group LLC now owns 30,358 shares of the real estate investment trust's stock valued at $551,000 after acquiring an additional 1,062 shares in the last quarter.
Insider Buying and Selling
In related news, Director Thomas N. Bohjalian acquired 7,750 shares of the company's stock in a transaction dated Friday, November 22nd. The shares were bought at an average price of $17.39 per share, for a total transaction of $134,772.50. Following the acquisition, the director now owns 50,002 shares in the company, valued at $869,534.78. This trade represents a 18.34 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Peter F. Sr Lyle, Sr. bought 10,000 shares of the firm's stock in a transaction that occurred on Friday, December 13th. The shares were purchased at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the completion of the transaction, the director now owns 26,576 shares of the company's stock, valued at $457,372.96. This represents a 60.33 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 18,750 shares of company stock valued at $323,723. Insiders own 0.56% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. Wedbush cut Healthcare Realty Trust from a "neutral" rating to an "underperform" rating and reduced their price objective for the company from $18.00 to $16.00 in a research report on Thursday. Jefferies Financial Group cut shares of Healthcare Realty Trust from a "buy" rating to a "hold" rating and reduced their target price for the company from $19.00 to $17.00 in a research note on Thursday. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an "overweight" rating to a "neutral" rating and set a $19.00 price target on the stock. in a research note on Friday, December 20th. Finally, Wells Fargo & Company reaffirmed an "underweight" rating and issued a $17.00 price objective (up previously from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $17.14.
Read Our Latest Analysis on HR
Healthcare Realty Trust Price Performance
Shares of NYSE HR traded down $0.02 during trading hours on Monday, hitting $16.55. 5,401,185 shares of the stock were exchanged, compared to its average volume of 4,070,495. Healthcare Realty Trust Incorporated has a one year low of $12.77 and a one year high of $18.90. The company's 50 day moving average is $17.49 and its 200 day moving average is $17.57. The firm has a market capitalization of $5.87 billion, a P/E ratio of -10.47 and a beta of 0.94.
Healthcare Realty Trust Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Tuesday, November 12th were paid a $0.31 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 7.49%. Healthcare Realty Trust's payout ratio is presently -78.48%.
About Healthcare Realty Trust
(
Free Report)
Healthcare Realty NYSE: HR is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Featured Stories
Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.